SIO GENE THERAPIES INC (SIOX)
Institutional ownership reported to the SEC as of Q2 2023, across 11 quarters.
1
Reporting holders
$26.0K
Reported value
0.0%
Held as options
-3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MACQUARIE GROUP LTD | $26.0K | 64,170 | 0.00% | 11q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $26.0K | 64,170 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 4 | $1.2M | 2,877,297 | 1 | 1 | 1 | 0.0% |
| Q4 2022 | 31 | $7.7M | 17,892,509 | 11 | 3 | 8 | 0.0% |
| Q3 2022 | 29 | $6.1M | 21,677,474 | 3 | 5 | 6 | 0.0% |
| Q2 2022 | 30 | $7.7M | 21,405,059 | 6 | 4 | 11 | 0.1% |
| Q1 2022 | 32 | $12.9M | 19,229,282 | 1 | 5 | 18 | 0.5% |
| Q4 2021 | 45 | $31.0M | 23,747,396 | 4 | 14 | 12 | 1.4% |
| Q3 2021 | 52 | $41.0M | 18,370,771 | 12 | 13 | 11 | 2.9% |
| Q2 2021 | 46 | $57.3M | 20,623,406 | 11 | 12 | 12 | 2.1% |
| Q1 2021 | 49 | $54.2M | 20,367,312 | 12 | 11 | 14 | 1.8% |
| Q4 2020 | 55 | $48.2M | 16,049,761 | 55 | 0 | 0 | 7.4% |